Work Medical posts 19.1% revenue rise in six months to March 31, 2026, citing higher mask orders and China VBP-driven device volumes

• Work Medical Technology Group posted revenue of $5.4 million for the six months ended March 31, 2026, up 19.1%.
• Growth was driven by higher medical device sales volume tied to centralized procurement, offset by lower pricing pressure on margins.
• Mask revenue rose 38% on higher demand and preferential pricing that lifted order volumes, despite a broader post-pandemic market downturn.
• Gross margin fell to 19.1% from 34.4% as lower-margin masks grew as a share of sales and procurement pricing compressed device profitability.
• Net loss widened to $3.46 million; cash and cash equivalents declined to about $3.25 million from about $4.09 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Work Medical Technology Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-090147), on August 14, 2026, and is solely responsible for the information contained therein.